Showing results (331-340 of 401) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2023
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal LymphadenopathySiamak Daneshmand, Clint Cary, Timothy Masterson, et al.
European Urology|July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
The Journal of Urology|April 9, 2025
Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS TrialBrian Hu, Muhannad Alsyouf, Ala'a Farkouh, et al.
The Journal of Urology|June 18, 2016
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant ChemotherapyWilhelmina C M Duivenvoorden, Siamak Daneshmand, Daniel Canter, et al.
Cancer|March 26, 2020
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA resultsSumanta K Pal, Dean Bajorin, Nazli Dizman, et al.
Urology|October 17, 2017
Variation in Radiologic and Urologic Computed Tomography Interpretation of Urinary Tract Stone Burden: Results From the Registry for Stones of the Kidney and UreterDavid T Tzou, Dylan Isaacson, Manint Usawachintachit, et al.
European Urology|March 21, 2020
Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder CancerHugh Mostafid, Marko Babjuk, Bernard Bochner, et al.
NPJ Digital Medicine|March 23, 2025
Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learningZilong Bai, Mohamed Osman, Matthew Brendel, et al.
European Urology|July 13, 2024
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 TrialElizabeth R Plimack, Catherine Tangen, Melissa Plets, et al.
Cancers|April 13, 2024
Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter RegistrySeyedeh-Sanam Ladi-Seyedian, Alireza Ghoreifi, Badrinath Konety, et al.
Pageof 41